Scintilla Comm (538857)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Trades at a 51% discount to stated book value (P/B 0.49 vs book value ₹10.21).
• ROCE is positive at 0.47%, indicating the capital base is not entirely idle.
• Latest quarter's net loss is negligible (₹-0 Cr), limiting immediate cash erosion.
• At a market cap of just ₹5 crore, the absolute size is tiny, creating possible special-situation appeal if assets are realisable.

Concerns

• Latest quarter shows zero sales and overall sales declined 18.75%, so the business appears non-operative.
• Negative ROE of -1.54% and profit growth of -728.57% suggest continued erosion of book value.
• Piotroski F-Score of 3/9 points to weak financial health.
• Promoter holding is undisclosed and dividend yield is zero, reflecting poor transparency and no shareholder return.

AI Analysis

When I look at Scintilla Comm, the first thing I see is a tiny NBFC with a market capitalisation of just ₹5 crore and a share price of ₹5.05. A price-to-book ratio of 0.49 suggests Mr. Market values every ₹10.21 of book value at only half that amount. That looks like a Graham-style bargain, but low price alone is never enough. A cheap stock can always become cheaper if the underlying assets are weak or the business cannot earn its keep. Here, return on equity is -1.54%, and the latest quarter shows no sales and only a negligible loss. A company with zero revenue that is still losing money will eventually eat into its book value, no matter what the balance sheet says today. The 728.57% collapse in profit growth and an 18.75% decline in sales reinforce my caution. The Piotroski score is just 3 out of 9, a clear sign of financial stress. With no dividend payment, no promoter holding data, and a share price already below the 52-week low of ₹5.70, there is no margin of safety in either the income stream or market support. ROCE is barely positive at 0.47%, but an NBFC must earn a return above the cost of capital to survive, and negative ROE tells me it is not doing so. This is not a wonderful business; it is an asset play with serious unanswered questions. I would study it only if an independent audit confirms the realisable value of the loan book, and if management can show a credible plan to restart earning income. Until then, buying this stock is not investing; it is speculation on an obscure, poorly disclosed balance sheet. I would rather pass and wait for something clearer.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer